Medicine and Health Sciences Commons^™

Patient Portals In Pharmacist-Run Ambulatory Care Clinics: Is There “Meaningful Use”?, H. Paige Erdeljac, Melissa J. Snider, Kelly Bartsch, Raul Weiss

Excerpts in Pharmacy Research Journal

Objective

The purpose of this study is to describe patient portal utilization within pharmacist-managed clinics at an academic medical center from the perspectives of the institution, healthcare team, and patient. This study measures the progress toward meeting requirements for meaningful use per the Centers for Medicare and Medicaid Services (CMS).

Methods

The study included patients in pharmacist-managed clinics and consisted of a retrospective chart review and patient survey. Primary endpoints consisted of: 1) report progress toward meeting CMS criteria for meaningful use in subset of patients seen in the pharmacy-managed clinics, 2) describe utilization of patient portal across the healthcare …

Implementation Of An Outpatient, Pharmacist-Directed Clinic For Chronic Obstructive Pulmonary Disease, Heather N. Folz, Bethany L. Murphy

Excerpts in Pharmacy Research Journal

Objective: To describe development and challenges of implementing a pharmacist-led chronic obstructive pulmonary disease (COPD) clinic in the primary care setting.

Methods: Starting in October 2014, patients scoring 10-30 on the COPD Assessment Test (CAT) were assigned to the intervention or control group. Intervention patients met with a pharmacist, who provided medication and lifestyle counseling and therapy recommendations to the patients’ primary provider per protocol. Control patients were encouraged to make an appointment with their primary provider for standard care. Two months following the initial CAT administration, the survey was administered again to both study groups by phone. The …

Lack Of Cross-Reactivity Allergy Following A Switch From Alirocumab To Evolocumab, Matthew D. Stryker, Michael Kane, Robert Busch

Excerpts in Pharmacy Research Journal

The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene and gain-of-function mutations were first described in 2003. The gain-of-function mutations observed were associated with low-density lipoprotein-cholesterol (LDL-C) levels in the 400’s, in addition to premature cardiovascular disease. Subsequent loss-of-function experiments conducted in mice demonstrated marked reductions in plasma cholesterol levels in the absence of PCSK9. Physiologically, PCSK9 serves as a chaperone protein and functions to reduce low-density lipoprotein (LDL) receptor recycling; consequently, less LDL-C is removed from circulation and serum lipid concentrations become elevated. Inhibition of PCSK9 prevents LDL receptor degradation and preserves receptor recycling to the hepatocyte surface; this in …

Modeling With Medicinal Chemistry: Practical Innovative Technology-Based Activity To Enhance Student’S Learning Through Inter-Departmental Collaboration: Part I, Miriam Ansong, Denise Simpson, Nicole K. Stute

Excerpts in Pharmacy Research Journal

Background: Concepts of formulary management and its applications in clinical practice is a challenge faced by many first professional year pharmacy students. This challenge may be attributed to a lack of foundational knowledge and practical skills at this level. Preparing students for lifelong learning mandates early exposure to practical application of concepts. This warrants the need for students to integrate knowledge, skills, abilities, and attitudes in clinical practice. As a result, a state-of-the-art one stop shopping structure of the day (SOD) activity was created for P1 pharmacy students to enable the authors to assess their skill sets.

Objective: The objective …

Research And Publication Highlights, Miriam Ansong

Excerpts in Pharmacy Research Journal

Bibliography of completed research and book chapters